CTOs on the Move

Institute for Medical Research

www.imr.org

 
Institute for Medical Research is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.imr.org
  • 508 Fulton St
    Durham, NC USA 27705
  • Phone: 919.286.0411

Executives

Name Title Contact Details

Similar Companies

Visiting Angels Living Assistance Services

Visiting Angels Living Assistance Services is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Advanced Aeromedical Inc

Advanced Aeromedical Inc is a Virginia Beach, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sciformix

We are a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to biopharmaceutical, generic pharmaceutical, consumer product, medical device, contract research and healthcare companies. We partner with our clients through the entire drug development cycle to provide a broad range of services from study design to post marketing surveillance and commercialization support. We deliver consistent quality and compliance across the services by employing scientific rigor in combination with streamlined process, optimal technology and efficient people practices.

OncoGenex

OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.

Meta Pharmaceutical Services

Meta Pharmaceutical Services is a Blue Bell, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.